Analystreport

Allogene Therapeutics (NASDAQ:ALLO) was downgraded by analysts at Wall S

Allogene Therapeutics, Inc.  (ALLO) 
Last allogene therapeutics, inc. earnings: 2/27 04:30 am Check Earnings Report